ATE371041T1 - Kontrolle der immunantworten durch regulierung der aktivität von glykosyltransferasen - Google Patents
Kontrolle der immunantworten durch regulierung der aktivität von glykosyltransferasenInfo
- Publication number
- ATE371041T1 ATE371041T1 AT98925161T AT98925161T ATE371041T1 AT E371041 T1 ATE371041 T1 AT E371041T1 AT 98925161 T AT98925161 T AT 98925161T AT 98925161 T AT98925161 T AT 98925161T AT E371041 T1 ATE371041 T1 AT E371041T1
- Authority
- AT
- Austria
- Prior art keywords
- immune responses
- activity
- regulating
- control
- glycosyl transferases
- Prior art date
Links
- 102000051366 Glycosyltransferases Human genes 0.000 title abstract 2
- 108700023372 Glycosyltransferases Proteins 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title abstract 2
- 108700014210 glycosyltransferase activity proteins Proteins 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 abstract 4
- 230000028993 immune response Effects 0.000 abstract 4
- 230000002401 inhibitory effect Effects 0.000 abstract 3
- 230000001404 mediated effect Effects 0.000 abstract 3
- 238000003786 synthesis reaction Methods 0.000 abstract 3
- -1 sialyl galactosides Chemical class 0.000 abstract 2
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000002452 interceptive effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4830397P | 1997-05-30 | 1997-05-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE371041T1 true ATE371041T1 (de) | 2007-09-15 |
Family
ID=21953820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98925161T ATE371041T1 (de) | 1997-05-30 | 1998-05-29 | Kontrolle der immunantworten durch regulierung der aktivität von glykosyltransferasen |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6376475B1 (enExample) |
| EP (1) | EP1017846B1 (enExample) |
| JP (2) | JP4451933B2 (enExample) |
| AT (1) | ATE371041T1 (enExample) |
| AU (1) | AU7717598A (enExample) |
| DE (1) | DE69838298T2 (enExample) |
| WO (1) | WO1998054365A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7192914B1 (en) * | 1999-09-30 | 2007-03-20 | The Regents Of The University Of California | Prevention of atherosclerosis and undesired blood clotting by reducing von Willebrand factor |
| WO2001022921A2 (en) * | 1999-09-30 | 2001-04-05 | The Regents Of The University Of California | Prevention of atherosclerosis and undesired blood clotting by reducing von willebrand factor |
| CA2429625C (en) | 2000-10-18 | 2012-05-01 | Robert Sackstein | Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof |
| US20060210558A1 (en) * | 2000-10-18 | 2006-09-21 | Robert Sackstein | Hematopoietic cell selectin ligand polypeptides and methods of use thereof |
| DK1437358T3 (da) * | 2001-08-16 | 2007-02-05 | Daiichi Asubio Pharma Co Ltd | Hidtil ukendt glycolipid og medikament til autoimmune sygdomme indeholdende dette som det aktive stof |
| US20060074047A1 (en) * | 2004-10-06 | 2006-04-06 | Cross Alan S | Method of treating inflammation with inhibitors of sialyl transferases |
| JP4359779B2 (ja) * | 2006-01-23 | 2009-11-04 | ソニー株式会社 | 音響再生装置および音響再生方法 |
| GB0614947D0 (en) * | 2006-07-27 | 2006-09-06 | Isis Innovation | Epitope reduction therapy |
| CN102076865B (zh) | 2008-05-02 | 2016-03-16 | 西雅图基因公司 | 用于制造核心岩藻糖基化降低的抗体和抗体衍生物的方法和组合物 |
| WO2012019165A2 (en) | 2010-08-05 | 2012-02-09 | Seattle Genetics, Inc. | Methods of inhibition of protein fucosylation in vivo using fucose analogs |
| CA2818917C (en) * | 2010-12-16 | 2023-02-28 | Basf Se | Plants having increased tolerance to herbicides |
| JP2014159374A (ja) * | 2011-05-20 | 2014-09-04 | Nippon Nohyaku Co Ltd | 作物の枯凋落葉剤組成物 |
| AR091489A1 (es) * | 2012-06-19 | 2015-02-11 | Basf Se | Plantas que tienen una mayor tolerancia a herbicidas inhibidores de la protoporfirinogeno oxidasa (ppo) |
| CA2882725C (en) | 2012-08-23 | 2021-03-09 | Regents Of The University Of Minnesota | Treatment of sickle cell disease and inflammatory conditions |
| JP2016027002A (ja) * | 2012-11-16 | 2016-02-18 | 日本農薬株式会社 | 除草剤組成物 |
| EP2993184B1 (en) | 2013-05-02 | 2019-03-13 | National Institute of Advanced Industrial Science and Technology | Monoclonal antibody recognizing sialylated sugar chains |
| US10285976B2 (en) | 2013-08-12 | 2019-05-14 | The Board Of Trustees Of The Leland Stanford Junior University | 4-methylumbelliferone treatment for immune modulation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5352462A (en) * | 1982-06-03 | 1994-10-04 | Stolle Research & Development Corporation | Anti-inflammatory factor, method of isolation, and use |
| US5288854A (en) * | 1990-11-28 | 1994-02-22 | Center For Blood Research, Inc. | Functional derivatives of ICAM-1 which are substantially capable of binding to LFA-1 but are substantially incapable of binding to MAC-1 |
| US5461143A (en) * | 1991-03-18 | 1995-10-24 | The Scripps Research Institute | Oligosaccharide enzyme substrates and inhibitors: methods and compositions |
| JPH05247078A (ja) | 1992-03-03 | 1993-09-24 | Japan Tobacco Inc | 糖化合物、シアル酸含有糖鎖類生合成阻害剤、その製造方法、並びに新規な中間体 |
| US5453272A (en) | 1992-10-02 | 1995-09-26 | Alberta Research Council | Lectin derived carbohydrate binding-peptide |
| AU2828595A (en) | 1994-06-15 | 1996-01-05 | Alexion Pharmaceuticals, Inc. | Methods for reducing hyperacute rejection of xenografts |
| AU2001296705A1 (en) * | 2000-10-06 | 2002-04-15 | The Regents Of The University Of California | Blocking inflammation by inhibiting sialylation |
-
1996
- 1996-12-27 JP JP52994198A patent/JP4451933B2/ja not_active Expired - Fee Related
-
1998
- 1998-05-29 DE DE69838298T patent/DE69838298T2/de not_active Expired - Lifetime
- 1998-05-29 AU AU77175/98A patent/AU7717598A/en not_active Abandoned
- 1998-05-29 EP EP98925161A patent/EP1017846B1/en not_active Expired - Lifetime
- 1998-05-29 AT AT98925161T patent/ATE371041T1/de not_active IP Right Cessation
- 1998-05-29 WO PCT/US1998/011260 patent/WO1998054365A1/en not_active Ceased
- 1998-05-29 US US09/087,117 patent/US6376475B1/en not_active Expired - Lifetime
- 1998-05-29 JP JP50102499A patent/JP2002528037A/ja not_active Ceased
-
2002
- 2002-04-23 US US10/131,721 patent/US20030013636A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1017846A1 (en) | 2000-07-12 |
| DE69838298D1 (de) | 2007-10-04 |
| EP1017846A4 (en) | 2004-08-11 |
| DE69838298T2 (de) | 2008-05-15 |
| WO1998054365A1 (en) | 1998-12-03 |
| US20030013636A1 (en) | 2003-01-16 |
| AU7717598A (en) | 1998-12-30 |
| JP4451933B2 (ja) | 2010-04-14 |
| EP1017846B1 (en) | 2007-08-22 |
| US6376475B1 (en) | 2002-04-23 |
| JP2002528036A (ja) | 2002-08-27 |
| JP2002528037A (ja) | 2002-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69838298D1 (de) | Kontrolle der immunantworten durch regulierung der aktivität von glykosyltransferasen | |
| IL122782A (en) | Triazole salts and pharmaceutical compositions containing the same and methods for evaluating the susceptibility of a cancer to growth inhibition utilizing the same | |
| NO974457L (no) | Inhibitorer for farnesylproteintransferase | |
| MX206851B (es) | Aril o heteroarilamidas sustituidas que tienen actividad biologica similar a los retinoides. | |
| ATE286133T1 (de) | Zellfreie synthese von polyketiden | |
| DE59204017D1 (de) | Glanzpigmente auf der basis von mehrfach beschichteten plättchenförmigen silikatischen substraten. | |
| DE60038917D1 (de) | Campylobacter Glycolsyltransferasen zur Verwendung bei der Biosynthese von Gangliosiden und ganglioside Imitatoren | |
| MY121808A (en) | Module for interconnecting two monopair lines | |
| ATE5960T1 (de) | Metallchelate von 1,4-bis-(substituiertes amino-)-5,8-dihydroxy-anthrachinonen. | |
| DK0463592T3 (da) | 2,4- og 2,5-substituerede pyridin-N-oxider, fremgangsmåder til deres fremstilling samt deres anvendelse | |
| DE69205171D1 (de) | Grundiermittel für Silikonsubstrate. | |
| TR199800243T1 (xx) | Prolil endopeptidaz inhibit�rleri. | |
| DE69200861D1 (de) | Konzentration von tert.-Butyl-Hydroperoxid. | |
| PL330786A1 (en) | Inhibitors of prenyl transferase | |
| EP0648279A4 (en) | FUCOSYLTRANSFERASE ACCEPTOR. | |
| DE3767728D1 (en) | Hydroxylierte 1,2-diamincyclohexan platinkomplexe. | |
| NO894494L (no) | Vandige kunstharpiksdispersjoner, samt fremgangsmaate for fremstilling av dem, og anvendelse av dispersjonene. | |
| DE69205983D1 (de) | Beschichtung von substraten. | |
| EP0146711A3 (en) | 2-hydrazino-1h-imidazoles | |
| DE59100469D1 (de) | Kabelkanal für winkelelemente von büromöbel-winkelkombinationen. | |
| ES2173634T3 (es) | Compuestos heterociclicos que presentan actividad inhibidora de mmp y tnf. | |
| AP9300577A0 (en) | Cyanophenyl-pyrazolines. | |
| UA15337A (uk) | Пристрій для мажоритарhого вибору асиhхроhhих сигhалів | |
| BACHEM et al. | The schedule of the conference, and correspondingly the papers of this issue, covered the following areas within Combinatorial Optimization.-Algorithms for NP-complete problems | |
| ES279120U (es) | Ensamble modular de carpinteria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |